Molecular basis of von Willebrand disease and its clinical implications

Haematologica. 2004 Sep;89(9):1036.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Deamino Arginine Vasopressin / therapeutic use
  • Factor VIII / therapeutic use
  • Humans
  • Mutation
  • von Willebrand Diseases / classification
  • von Willebrand Diseases / drug therapy
  • von Willebrand Diseases / genetics*
  • von Willebrand Factor / genetics*
  • von Willebrand Factor / therapeutic use

Substances

  • von Willebrand Factor
  • Factor VIII
  • Deamino Arginine Vasopressin